Skip to main content
. 2021 Feb 1;29(8):4763–4772. doi: 10.1007/s00520-021-06018-x

Fig. 3.

Fig. 3

Time to resolution of denosumab- or zoledronic acid-related osteonecrosis of the jaw in patients with bone metastases. A total of 34 patients who developed MRONJ were evaluated. MRONJ, medication-related osteonecrosis of the jaw